About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Chicago | 167 Studies

Clinical Trials Alzheimer's DiseaseChicago

Alzheimer's Disease Clinical Trials in Chicago

Find 167 clinical trials for alzheimer's disease near Chicago, Illinois. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 167 trials

CompletedClinical Evaluation of Florbetapir F 18 (18F-AV-45)This protocol is designed to standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden in subjects participating in other studies (companion…NCT01518374·Phoenix, Arizona and 25 others CompletedCERE-110 in Subjects With Mild to Moderate Alzheimer's DiseaseThis is a Phase I clinical study to assess the safety, tolerability and biologic activity of in vivo AAV-mediated delivery of CERE-110.NCT00087789·San Diego, California and 1 other

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedSimufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's DiseaseA 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 76 weeks.NCT05026177·Phoenix, Arizona and 88 others

CompletedA Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the safety and efficacy of MABT5102A in patients with mild to moderate…NCT01343966·Phoenix, Arizona and 91 others

Active not recruitingA Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in…NCT06653153·Birmingham, Alabama and 261 others

RecruitingFeasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related OutcomesThis remote study will evaluate the feasibility of using the Gatorade Sports Science Institute (GSSI) Labs App for remotely collecting hydration related outcomes.NCT07005895·Chicago, Illinois

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to…NCT00575055·Birmingham, Alabama and 185 others

CompletedComparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineThe purpose of this study was to support the optimal use of rivastigmine patch in long-term treatment of Alzheimer's Disease in patients demonstrating functional and cognitive…NCT00506415·Birmingham, Alabama and 144 others

RecruitingScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesThis study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.NCT07177352·Birmingham, Alabama and 233 others

CompletedEffect of LY450139 on the Long Term Progression of Alzheimer's DiseaseAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00594568·Birmingham, Alabama and 147 others

CompletedAn Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeObjectives: The objective of this study will be to determine the safety, tolerability, drug blood levels, and efficacy of each of three doses of NS 2330 (Tesofensine) given once…NCT00153010·Mesa, Arizona and 86 others

SuspendedA Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.NCT04520412·Gilbert, Arizona and 170 others

Active not recruitingA Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseThis is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to…NCT05531656·Birmingham, Alabama and 49 others

CompletedDecision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older AdultsThis study seeks to better understand how older adult aging-in-place/long term care decision making and implementation is impacted by age-related changes (e.g. cognition, health…NCT03960476·Chicago, Illinois

RecruitingCentral Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory MusicThis study examines whether Clinically Designed Improvisatory Music (CDIM) can reduce anxiety in people living with Alzheimer's disease and anxiety (AD-A), and whether it can also…NCT07775625·Chicago, Illinois

CompletedFlorbetaben PET Imaging in PPAThe purpose of this research is to better understand how dementia affects activity in different parts of the brain.NCT04720001·Chicago, Illinois

TerminatedAD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseThe purpose of this study is to evaluate the effect of pioglitazone at 24 months compared with placebo on cognitive decline in high-risk participants who have completed the…NCT02284906·Phoenix, Arizona and 42 others

CompletedA Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseThis is a multinational, multicenter, double-blind, placebo-controlled, parallel-group study using a Bayesian design with response adaptive randomization across placebo or 5…NCT01767311·Birmingham, Alabama and 168 others

TerminatedStudy to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeThis study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for…NCT04464564·Phoenix, Arizona and 105 others

WithdrawnImplementation of AIP Services for Older Adults With ADThis study will longitudinally follow a cohort of older adults to better understand how decisions about aging in place or transitioning to long-term care-and the implementation of…NCT07361601·Chicago, Illinois

PreviousPage 5 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia